rs201333414
Variant summary
Our verdict is Benign. Variant got -7 ACMG points: 2P and 9B. PM2BP4_StrongBP6BS1
The NM_032806.6(POMGNT2):c.499G>A(p.Val167Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000923 in 1,614,116 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_032806.6 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -7 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
POMGNT2 | NM_032806.6 | c.499G>A | p.Val167Ile | missense_variant | 2/2 | ENST00000344697.3 | NP_116195.2 | |
POMGNT2 | XM_005265515.4 | c.499G>A | p.Val167Ile | missense_variant | 3/3 | XP_005265572.1 | ||
POMGNT2 | XM_011534163.3 | c.499G>A | p.Val167Ile | missense_variant | 3/3 | XP_011532465.1 | ||
POMGNT2 | XM_017007353.2 | c.499G>A | p.Val167Ile | missense_variant | 4/4 | XP_016862842.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
POMGNT2 | ENST00000344697.3 | c.499G>A | p.Val167Ile | missense_variant | 2/2 | 1 | NM_032806.6 | ENSP00000344125.2 |
Frequencies
GnomAD3 genomes AF: 0.000105 AC: 16AN: 152140Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000187 AC: 47AN: 251324Hom.: 0 AF XY: 0.000169 AC XY: 23AN XY: 135850
GnomAD4 exome AF: 0.0000910 AC: 133AN: 1461858Hom.: 0 Cov.: 37 AF XY: 0.0000866 AC XY: 63AN XY: 727224
GnomAD4 genome AF: 0.000105 AC: 16AN: 152258Hom.: 0 Cov.: 33 AF XY: 0.000107 AC XY: 8AN XY: 74446
ClinVar
Submissions by phenotype
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | Mar 12, 2024 | In silico analysis supports that this missense variant does not alter protein structure/function; Has not been previously published as pathogenic or benign to our knowledge - |
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 8 Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Apr 30, 2023 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at